Madam Speaker, my colleague's question is very important. As I said throughout my speech, I do not have a lot of experience in vapour products, but so far we know that they are less harmful. The question is how much less.
As we move forward, we will need to do much more research, but at least the regulation now would force the industry to clearly stipulate or show evidence of how this is going to fall under the Food and Drugs Act and how it is therapeutic. The research will need to continue, as with any other product. This product has been out there for eight or nine years without regulations. Now we are bringing in regulations, but the real question will be to what extent the risk is less. Is it 80% less, or 20% less? That may force other changes.
I agree with my colleague that we would need to invest in research in this area. Who is investing? Those are discussions that could be had through municipal governments, provincial governments, and the federal government.